- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant human alpha-Mannosidase
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant human alpha-Mannosidase
| EU orphan designation number: | EU/3/04/260
|
| Active ingredient: | Recombinant human alpha-Mannosidase |
| Indication: | Treatment of alpha-Mannosidosis |
| Sponsor: | Zymenex A/S
Roskildevej 12C, DK-3400 Hillerød, Danmark |
Public summary of scientific opinion
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 28/01/2005 | Centralised Orphan - Designation | EMEA/OD/074/04 | (2005)242 of 26/01/2005 | |||
| 04/02/2005 | Other procedure |
CONTACT
EU links
Directorate General Health & Consumers